149 related articles for article (PubMed ID: 12082028)
1. Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay.
Shibutani M; Takahashi N; Kobayashi T; Uneyama C; Masutomi N; Nishikawa A; Hirose M
Carcinogenesis; 2002 Jun; 23(6):1047-55. PubMed ID: 12082028
[TBL] [Abstract][Full Text] [Related]
2. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat.
Kitano M; Ichihara T; Matsuda T; Wanibuchi H; Tamano S; Hagiwara A; Imaoka S; Funae Y; Shirai T; Fukushima S
Carcinogenesis; 1998 Aug; 19(8):1475-80. PubMed ID: 9744545
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effects of phenobarbital and 3-methylcholanthrene on GST-P-positive liver cell foci development in a new medium-term rat liver bioassay using D-galactosamine.
Kim HC; Lee YS; Nishikawa A
J Toxicol Environ Health; 1997 Apr; 50(5):519-28. PubMed ID: 9140468
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effect of enzymatically modified isoquercitrin on phenobarbital-induced liver tumor promotion in rats.
Morita R; Shimamoto K; Ishii Y; Kuwata K; Ogawa B; Imaoka M; Hayashi SM; Suzuki K; Shibutani M; Mitsumori K
Arch Toxicol; 2011 Nov; 85(11):1475-84. PubMed ID: 21445586
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of preneoplastic lesion yield by Chios Mastic Gum in a rat liver medium-term carcinogenesis bioassay.
Doi K; Wei M; Kitano M; Uematsu N; Inoue M; Wanibuchi H
Toxicol Appl Pharmacol; 2009 Jan; 234(1):135-42. PubMed ID: 18977376
[TBL] [Abstract][Full Text] [Related]
6. Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine.
Williams GM; Gebhardt R; Sirma H; Stenbäck F
Carcinogenesis; 1993 Oct; 14(10):2149-56. PubMed ID: 8106178
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate (DHEP).
Richmond RE; Carter JH; Carter HW; Daniel FB; Deangelo AB
Carcinogenesis; 1996 Aug; 17(8):1647-55. PubMed ID: 8761421
[TBL] [Abstract][Full Text] [Related]
8. The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration.
Goldsworthy T; Campbell HA; Pitot HC
Carcinogenesis; 1984 Jan; 5(1):67-71. PubMed ID: 6140089
[TBL] [Abstract][Full Text] [Related]
9. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
[TBL] [Abstract][Full Text] [Related]
10. Short-term in vivo initiation/promotion bioassay for hepatocarcinogens.
Ford JO; Pereira MA
J Environ Pathol Toxicol; 1980 Nov; 4(5-6):39-46. PubMed ID: 6111580
[TBL] [Abstract][Full Text] [Related]
11. Modifying effects of liver tumor promotion in rats subjected to co-administration of indole-3-carbinol and phenobarbital.
Segawa R; Hayashi H; Morita R; Ogawa T; Takimoto N; Hara S; Suzuki K; Shibutani M; Mitsumori K
J Toxicol Sci; 2014 Feb; 39(1):129-40. PubMed ID: 24418717
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
[TBL] [Abstract][Full Text] [Related]
13. [Dose-response relationship of promotion by phenobarbital in rat two-stage hepatocarcinogenesis].
Onodera H; Matsushima Y; Uneyama C; Shibutani M; Mitsumori K; Maekawa A; Hayashi Y
Eisei Shikenjo Hokoku; 1991; (109):55-60. PubMed ID: 1364405
[TBL] [Abstract][Full Text] [Related]
14. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals.
Ito N; Tamano S; Shirai T
Cancer Sci; 2003 Jan; 94(1):3-8. PubMed ID: 12708466
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for chemopreventive potential of beta-carotene against experimental carcinogenesis: diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis is prevented more effectively by beta-carotene than by retinoic acid.
Bishayee A; Sarkar A; Chatterjee M
Nutr Cancer; 2000; 37(1):89-98. PubMed ID: 10965525
[TBL] [Abstract][Full Text] [Related]
16. Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine.
Okada N; Honda A; Kawabata M; Yajima N
Mutagenesis; 1997 May; 12(3):179-84. PubMed ID: 9175645
[TBL] [Abstract][Full Text] [Related]
17. Threshold dose dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine.
Maekawa A; Onodera H; Ogasawara H; Matsushima Y; Mitsumori K; Hayashi Y
Carcinogenesis; 1992 Mar; 13(3):501-3. PubMed ID: 1347716
[TBL] [Abstract][Full Text] [Related]
18. Dose-related increases in quantitative values for altered hepatocytic foci and cytochrome P-450 levels in the livers of rats exposed to phenobarbital in a medium-term bioassay.
Hagiwara A; Matsuda T; Tamano S; Kitano M; Imaoka S; Funae Y; Takesada Y; Shirai T; Fukushima S
Cancer Lett; 1996 Dec; 110(1-2):155-62. PubMed ID: 9018095
[TBL] [Abstract][Full Text] [Related]
19. Enhanced liver tumor promotion activity in rats subjected to combined administration of phenobarbital and orphenadrine.
Morita R; Yafune A; Shiraki A; Itahashi M; Akane H; Nakane F; Suzuki K; Shibutani M; Mitsumori K
J Toxicol Sci; 2013; 38(3):415-24. PubMed ID: 23665940
[TBL] [Abstract][Full Text] [Related]
20. Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2',5'-tetrachlorobiphenyl, and/or 3,4,3'4'-tetrachlorobiphenyl in rat liver.
Sargent LM; Sattler GL; Roloff B; Xu YH; Sattler CA; Meisner L; Pitot HC
Cancer Res; 1992 Feb; 52(4):955-62. PubMed ID: 1737357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
